Preclinical evaluation of drug—drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction
- 1 November 1997
- journal article
- review article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 107 (1-2) , 5-16
- https://doi.org/10.1016/s0009-2797(97)00070-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Induction of cytochrome P450 3A by metyrapone in human hepatocyte cultureHuman & Experimental Toxicology, 1996
- Polybrominated biphenyl induction of cytochrome P450 mixed function oxidase activity in primary rat and human hepatocytesToxicology, 1995
- Pharmacokinetic variability of zidovudine in HIV-infected individualsAIDS, 1994
- Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies.Environmental Health Perspectives, 1994
- HepG2 Cells: An in Vitro Model for P450-Dependent Metabolism of AcetaminophenBiochemical and Biophysical Research Communications, 1993
- Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptorBiochemical and Biophysical Research Communications, 1992
- Purification of two cytochrome P450 isozymes related to CYP2A and CYP3A gene families from monkey (baboon, Papio papio) liver microsomesEuropean Journal of Biochemistry, 1992
- Expression of cytochrome P‐450 enzymes in cultured human hepatocytesEuropean Journal of Biochemistry, 1990
- Optimization of Cryopreservation Procedures for Rat and Human HepatocytesXenobiotica, 1989
- HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLSThe Journal of cell biology, 1969